ICOS Promotes T Cell Activation and Function Beyond Phosphoinositide 3-Kinase Signaling (126.11)

Xue-Zhong Yu,Kenrick Semple,Julien Leconte,Woong-Kyung Suh,Jun Li

DOI: https://doi.org/10.4049/jimmunol.188.supp.126.11

2012-01-01

The Journal of Immunology

Abstract:ICOS delivers an important costimulation to promote T-cell activation and function. Using a knock-in mouse strain, termed ICOS-YF, in which the cytoplasmic tail of ICOS cannot activate phosphoinositide 3-kinase (PI3K), we have shown that ICOS-PI3K signaling axis is critical for generation of follicular helper T cells. Although ICOS can potentiate TCR-mediated calcium flux in a PI3K-independent manner, its biological significance is unclear. To address this question, we studied the function of ICOS-YF T cells in comparison with ICOS wild-type (WT) and knock-out (KO) T cells in MHC-mismatched bone marrow transplantation (BMT) models. We found that CD4 T cells from ICOS-YF and KO mice were similarly impaired in their capacity to induce acute graft-versus-host disease (GVHD). In contrast, the pathogenic capacity of CD8 T cells from ICOS-YF mice was comparable to that of WT cells, whereas ICOS KO CD8 T cells were less pathogenic. In vitro, we observed that in both CD4 and CD8 T cells ICOS could potentiate TCR-mediated calcium flux in a PI3K-independent manner. These results suggest that although both CD4 and CD8 T cells depend on ICOS costimulation, the downstream signaling pathways they utilize are distinct: CD4 T cells depend on ICOS-PI3K signaling whereas CD8 T cells are more dependent on PI3K-independent pathways, probably calcium signaling. Taken together, our study reveals a complexity in ICOS signaling mechanisms in GVHD.